Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Bicara Therapeutics Inc. | 2,392,150 | 1,822,150 | -570,000 | $47.58M | $54.10M | 29.14% | +$6.52M |
| Nuvation Bio Inc.CL A(NUVB) | 8,081,089 | 8,081,089 | 0 | $34.67M | $45.90M | 24.72% | +$11.23M |
| Kestra Med Technologies Ltd SHS | 1,022,149 | 1,022,149 | 0 | $20.37M | $26.00M | 14.00% | +$5.63M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 3,289,661 | 3,289,661 | 0 | $29.44M | $25.07M | 13.50% | -$4.38M |
| Beta Bionics, Inc.(BBNX) | 1,316,183 | 1,316,183 | 0 | $13.19M | $20.62M | 11.11% | +$7.44M |
| Alumis Inc. | 241,255 | 241,255 | 0 | $5.31M | $6.79M | 3.66% | +$1.47M |
| Sana Biotechnology, Inc.(SANA) | 843,750 | 843,750 | 0 | $2.43M | $2.94M | 1.59% | +$514.7K |
| ImageneBio, Inc.(IMA) | 455,361 | 455,361 | 0 | $2.28M | $2.69M | 1.45% | +$409.8K |
| enGene Holdings Inc. COM | 876,357 | 876,357 | 0 | $5.97M | $1.52M | 0.82% | -$4.45M |
| Odyssey Therapeutics Inc. | 0 | 2,893 | +2,893 | $0 | $54.1K | 0.03% | +$54.1K |
| Replimune Group, Inc.(REPL) | 248,672 | 0 | -248,672 | $1.91M | $0 | — | -$1.91M |